Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes.

MLA

Hulen, Thomas Morgan, et al. “Ex Vivo Modulation of Intact Tumor Fragments with Anti-PD-1 and Anti-CTLA-4 Influences the Expansion and Specificity of Tumor-Infiltrating Lymphocytes.” Frontiers in Immunology, Aug. 2024, pp. 1–15. EBSCOhost, https://doi.org/10.3389/fimmu.2023.1180997.

APA

Hulen, T. M., Friese, C., Kristensen, N. P., Granhøj, J. S., Borch, T. H., Peeters, M. J. W., Donia, M., Andersen, M. H., Hadrup, S. R., Svane, I. M., & Met, Ö. (2024). Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes. Frontiers in Immunology, 1–15. https://doi.org/10.3389/fimmu.2023.1180997

Chicago

Hulen, Thomas Morgan, Christina Friese, Nikolaj Pagh Kristensen, Joachim Stoltenborg Granhøj, Troels Holz Borch, Marlies J. W. Peeters, Marco Donia, et al. 2024. “Ex Vivo Modulation of Intact Tumor Fragments with Anti-PD-1 and Anti-CTLA-4 Influences the Expansion and Specificity of Tumor-Infiltrating Lymphocytes.” Frontiers in Immunology, August, 1–15. doi:10.3389/fimmu.2023.1180997.